Ģý

Country websites

Company profile

We are the leading provider of products and services for individuals with renal diseases.

Ģý is the worldĢýs leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Ģý offers products and services along the entire dialysis value chain from a single source. As of December 31, 2025, we cared for more than 292,000 patients in our global network of roughly 3,600 dialysis centers worldwide. At the same time, we operated around 35 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.

Ģý aims to further consolidate its expertise and to use this competence as a basis for sustainable, profitable growth. We aim to continuously improve our patientsĢý quality of life by offering them high-quality products as well as innovative technologies and treatment concepts.

ĢýĢýs corporate headquarters is in Bad Homburg v. d. Höhe, Germany. The headquarters in North America is in Waltham, Massachusetts, the headquarters of Asia-Pacific is located in Hongkong and the headquarters of Latin America is in Rio de Janeiro

Our history

1462
1951
1966
2003
2007
2013
2014
2016
2018
2019
2020
/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1912_e09f9fd0e3.jpg

1462

Foundation of the Hirsch Pharmacy is established in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1951_2e8586ce83.jpg

1951

Else Fernau, later Else Kröner, takes over the responsibility for the pharmacy and the company after obtaining her pharmacy degree.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_1966_66cfe6d46c.jpg

1966

Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2003_802e833016.jpg

2003

Ģý is the leading dialysis company, caring, for more than 119,000 patients in its own dialysis centres worldwide. With a production output of more than 50 million dialyzers per year, Ģý sets a new record.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2007_7d0c9e88cd.jpg

2007

Ģý continues its success as the leading manufacturer of dialyzers, producing its 500 millionth dialyzer.

/content/dam/fresenius-medical-care/czech/images/o-nas/profil-společnosti/csm_2013_6898f8685b.jpg

2013

Ģý produces its billionth dialyzer.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2014.jpg

2014

A new generation of home dialysis cyclers is launched Ģý sleepĢýsafe harmony Ģý enabling most individualized treatment options with adapted APD (aAPD) therapy.

/content/dam/fresenius-medical-care/hungary/images/betegek-és-családtagjaik/csm_2016_f1576f575b.jpg

2016

Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2018.jpg

2018

Ģý launches the 4008A dialysis machine tailored to needs in emerging markets.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2019.jpg

2019

By acquiring NxStage Medical, Inc., Ģý expands its product portfolio with an innovative technology for home dialysis offering patients greater flexibility.

/content/dam/fresenius-medical-care/global/en/06_about-us/images/history/timeline/2020.jpg

2020

Launch of the GlobalSustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years. Production of the 2-billionth dialyzer Ģý just seven years after the production of the 1-billionth.

Ģý in numbers (Full Year 2023)

  • Through our network of around4,000 dialysis clinics, we provide dialysis treatments to more than332,000 patients worldwide.
  • We offer dialysis productsin around 150 countries.
  • We performed around52 million dialysis treatments in 2023.
  • Around 120,000 employees work for Ģý worldwide.
  • We are the market leader in the production of hemodialysis machines.
  • We operate around 40production sites in around20 countries.
  • In 2023, Ģý generated revenue of around 19.45billion euros.

Major locations

Research and development

Developing innovative products and continuously improving our renal therapies are intrinsic elements of our growth strategy.

Our worldwide research and development activities, which are centrally managed by the Global Research and Development division (GRD), enable us to develop products and renal therapies efficiently and to systematically promote the exchange of knowledge and technology between regions.

Corporate culture

We strive to create a future worth living for dialysis patients.Worldwide.Everyday.

  • Collaborating
  • proactiveness
  • Reliability
  • Excellence

To learn more about our Corporate culture andmission, visit ourGlobal Website.

Sustainability

For us, sustainability means environmental and social progress as well as responsible action to achieve success at work.

  • We assume economic responsibility
  • We take responsibility for the environment
  • We assume social responsibility

To get more information about our responsibility, have a look at ourGlobal Website.

Compliance

As the market leader worldwide, Ģý is aware of its responsibility and takes it seriously. With our rules and company ethics we want to set standards that comply with our own and our stakeholdersĢý expectations.

Ģý is committed to conduct its business activities in compliance with local laws and regulations that apply to our business. We seek to demonstrate professionalism, honesty and integrity in our business relationships with patients, customers, suppliers, the government and other payors, fellow employees, investors and the general public.

Additionally Ģý has implemented business ethics and principles for business partners which outline the principles for all third parties acting on behalf of Ģý. The emphasis is on environmentally sound and resource-efficient production as well as fair and humane working conditions at our suppliers.

To learn more about compliance at Ģý, visit ourGlobal Website.

More information

For more information see the Downloads section on:

ĢýCompany Profile (Global website)

Do not hesitate to contact us for further information

Related content